Digital Content 
NEWS #PharmaBuzz
16 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-licensing-agreement-with-optus-pharmaceuticals-for-commercialization-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-in-korea-302277027.html
15 Oct 2024
// FINANCIALXPRESS
https://www.financialexpress.com/business/healthcare-tuberculosis-asthma-glaucoma-and-bipolar-disorder-medicines-to-get-costlier-by-50-percent-as-nppa-announces-price-hike-3641256/
14 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-strengthens-leadership-team-with-key-hires-to-support-the-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302274366.html
08 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-completes-78-million-financing-to-support-commercial-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302269236.html
19 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html
27 Jun 2023
// Kyle LaHucik ENDPTS
https://endpts.com/after-cutting-back-on-vuity-last-fall-abbvie-culls-a-second-gen-presbyopia-eye-drop/
LOOKING FOR A SUPPLIER?
Share